- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07551453
The Return-to-Work Experience of Cancer Patients: A Descriptive Phenomenological Study (REWORK)
April 22, 2026 updated by: Centro di Riferimento Oncologico - Aviano
This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience.
The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.
Study Overview
Status
Completed
Conditions
Detailed Description
This study explores the phenomenon of returning to work among individuals affected by cancer, with the objective of providing a description of their lived experience.
The ultimate goal is to understand the significance attributed to work, describing the extent to which it is perceived as a protective factor instrumental in restoring a sense of 'normality' and improving quality of life.
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pordenone
-
Aviano, Pordenone, Italy, 33081
- Centro Di Riferimento Oncologico Di Aviano
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study population consists of adult cancer patient (18+ years) diagnosed with any primary neoplasm, who are currently employed and undergoing active anticancer treatment (pharmacological, surgical, or radiological) in an outpatient or Day Hospital setting.
Description
Inclusion Criteria:
- Age: 18 years of age or older.
- Diagnosis: Primary diagnosis of neoplasm.
- Treatment: Currently undergoing at least one anticancer treatment (pharmacological/systemic therapy, surgery, or radiotherapy).
- Setting: Patients managed in a Day Hospital or outpatient setting.
- Employment Status: Engaged in paid and continuous professional activity at the time of diagnosis.
- Language: Ability to understand and speak the Italian language fluently.
- Informed Consent: Ability to provide written informed consent for study participation and data processing (privacy) in accordance with local regulations.
Exclusion Criteria:
- Pre-existing Unemployment: Individuals who were not employed prior to the onset of the disease.
- Psychiatric or Cognitive Impairment: Current diagnosis of psychiatric disorders or cognitive dysfunction that may interfere with the ability to participate in the interview.
- Terminal Prognosis: Patients with a diagnosis of terminal illness or end-of-life status.
- Lack of Voluntary Consent: Individuals who voluntarily choose not to participate in the project or withdraw consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Perception of Work Experience and Unmet Health Needs
Time Frame: up to 1 year
|
A qualitative assessment of how cancer patients perceive their professional life during treatment will be carried out using Colaizzi framework (1978).
The study uses semi-structured interviews to identify "unexpressed health needs"-specific physical, psychological, or organizational requirements related to working while undergoing therapy that are not currently addressed by standard care.
|
up to 1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of Potential Nursing Interventions for Work-Related Support
Time Frame: up to 1 year
|
Analysis of patient interviews using a qualitative approach to categorize and define specific nursing actions that can address the work-related health needs identified in the primary objective.
|
up to 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 17, 2024
Primary Completion (Actual)
September 30, 2025
Study Completion (Actual)
September 30, 2025
Study Registration Dates
First Submitted
April 13, 2026
First Submitted That Met QC Criteria
April 22, 2026
First Posted (Actual)
April 24, 2026
Study Record Updates
Last Update Posted (Actual)
April 24, 2026
Last Update Submitted That Met QC Criteria
April 22, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CRO-2024-051
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.